Goldstein: Expect More Litigation After Myriad

June 13 (Bloomberg Law) -- Tom Goldstein, partner at Goldstein & Russell, PC and founder of SCOTUSblog, talks with Bloomberg Law's Lee Pacchia about the United States Supreme Court's decision in the Association for Molecular Pathology v. Myriad Genetics, Inc. case. At issue was whether patents may be granted on parts of the human body. He also explores whether Justice Scalia's concurrence raises doubts whether he believes in molecular biology, and where patent litigation will head in the wake of the decision. Bloomberg Law is a sponsor of SCOTUSblog.
China Banks to Have 'Negative' Growth: Mizuho's Antos
04:32 - Jim Antos, an analyst at Mizuho Securities Asia Ltd. in Hong Kong, talks about China's banks. China Construction Bank Corp. joined the club of big Chinese banks reporting zero profit growth and rising bad loans as the government struggles to prop up the economy. Antos speaks with Rishaad Salamat on Bloomberg Television's "Trending Business." (Source: Bloomberg)
  • Investing In Asia's Future Female Leaders
  • Why Investors Say Malaysia Is Still a Good Option
  • China Slowing Has Less Effect on India: Rajan